Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Xiaoxian B. Li"'
Autor:
Uma Krishnamurti, Luicane Cavalli, Karuna Mittal, Shobhna Kapoor, Sergey Klimov, Shristi Bhattarai, Komal Arora, Chakravarthy Garlapati, Meenakshi V. Gupta, Xiaoxian B Li, Upender Manne, Ritu Aneja, Deepika Wali
Publikováno v:
Cancer Research. 80:P3-05
Background: Based on the expression of androgen receptor (AR), triple-negative breast cancer (TNBC) is subdivided into AR-positive and AR-negative subtypes. Although AR is a potential therapeutic target for AR-positive TNBC, its prognostic role in TN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f9144322552219e3d2a15707330413f
https://doi.org/10.1158/1538-7445.sabcs19-p3-05-02
https://doi.org/10.1158/1538-7445.sabcs19-p3-05-02
Autor:
Bital Savir-Baruch, Toncred M. Styblo, Mark M. Goodman, David M. Schuster, Mary S. Newell, Oluwaseun Odewole, Jonathon A. Nye, Anna I. Holbrook, Michael A. Cohen, Xiaoxian B. Li, Funmilayo Tade
Publikováno v:
Journal of Nuclear Medicine. 57:1357-1363
The purpose of this study was to explore the uptake of the synthetic amino acid analog PET radiotracer anti-3-18F-FACBC (18F-fluciclovine) in breast lesions with correlation to histologic and immunohistochemical characteristics. Methods: Twelve women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3078afaa68e8d9125d08d5aac6b9e499
https://doi.org/10.2967/jnumed.115.171389
https://doi.org/10.2967/jnumed.115.171389